The impact of patient heterogeneity and socioeconomic factors on abatacept retention in rheumatoid arthritis across nine European countries

by Finckh, A, Neto, D, Iannone, F, Loza, E, Lie, E, van Riel, P, Hetland, M L, Pavelka, K, Gottenberg, J E, Canhão, H, Mariette, X, Turesson, C
Published 2015

Rheumatoid Arthritis Patients after Initiation of a New Biologic Agent: Trajectories of Disease Activity in a Large Multinational Cohort Study

by Courvoisier, D.S., Alpizar-Rodriguez, D., Gottenberg, J.E., Hernandez, M.V., Iannone, F., Lie, E., Santos, M.J., Pavelka, K., Turesson, C., Mariette, X., Choquette, D., Hetland, M.L., Finckh, A.
Published 2016

2010 update of the ASAS/EULAR recommendations for the management of ankylosing spondylitis

by Braun, J, van den Berg, R, Baraliakos, X, Boehm, H, Burgos-Vargas, R, Collantes-Estevez, E, Dagfinrud, H, Dijkmans, B, Dougados, M, Emery, P, Geher, P, Hammoudeh, M, Inman, RD, Jongkees, M, Khan, MA, Kiltz, U, Kvien, TK, Leirisalo-Repo, M, Maksymowych, WP, Olivieri, I, Pavelka, K, Sieper, J, Stanislawska-Biernat, E, Wendling, D, Özgocmen, S, van Drogen, C, van Royen, BJ, van der Heijde, D
Published 2011